Evidence map›Paper›PMID 32240658›Full record

ArticleExperimental hematology2020

Deposition of Iron in the Bone Marrow of a Murine Model of Hematopoietic Acute Radiation Syndrome.

W Bradley Rittase, Jeannie M Muir, John E Slaven, Roxane M Bouten, Michelle A Bylicky, W Louis Wilkins, Regina M Day

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

W Bradley RittaseDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD.
Jeannie M MuirDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD.
John E SlavenDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD.
Roxane M BoutenDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD.
Michelle A BylickyRadiation Oncology Branch, National Cancer Institute, National Institutes of Health Bethesda, MD.
W Louis WilkinsDepartment of Laboratory Animal Research, Uniformed Services University of Health Sciences, Bethesda, MD.
Regina M DayDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD. Electronic address: regina.day@usuhs.edu.
Uniformed Services University of the Health Sciences · USNational Cancer Institute · USUniversity of Health Sciences

Funding

Enhancing cancer treatment by normal tissue protectionR01CA184168 · NCI · GEORGETOWN UNIVERSITY · PI FORNACE, ALBERT J · 2014 to 2018
$2.0M
NCI NIH HHS R01 CA184168
6 · The paper itself

Abstract

Exposure to high-dose total body irradiation (TBI) can result in hematopoietic acute radiation syndrome (H-ARS), characterized by leukopenia, anemia, and coagulopathy. Death from H-ARS occurs from hematopoietic insufficiency and opportunistic infections. Following radiation exposure, red blood cells (RBCs) undergo hemolysis from radiation-induced hemoglobin denaturation, causing the release of iron. Free iron can have multiple detrimental biological effects, including suppression of hematopoiesis. We investigated the impact of radiation-induced iron release on the bone marrow following TBI and the potential impact of the ACE inhibitor captopril, which improves survival from H-ARS. C57BL/6J mice were exposed to 7.9 Gy,

Indexed as

Acute Radiation SyndromeAnimalsBone MarrowCaptoprilErythrocytesFemaleGamma RaysGene Expression RegulationHematopoiesisIronMiceMice, TransgenicNF-E2-Related Factor 2Radiation Injuries, ExperimentalCaptoprilIronNfe2l2 protein, mouseNF-E2-Related Factor 2

Identifiers

PMID32240658
PMCPMC7265104
OpenAlexW3014185076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.